PMID: 11331420May 2, 2001Paper

Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects

Journal of Neurochemistry
Yogesh DwivediGhanshyam N Pandey

Abstract

The extracellular regulated kinases (ERK) 1 and ERK2 are members of mitogen-activated protein (MAP) kinase family that play an important role in transducing extracellular signals to the nucleus and have been implicated in a broad spectrum of biological responses. To test the hypothesis that MAP kinases may be involved in depression, we examined the activation of p44/42 MAP kinase and expression of ERK1 and ERK2 in the post-mortem brain tissue obtained from non-psychiatric control subjects (n = 11) and age- and the post-mortem interval-matched depressed suicide subjects (n = 11). We observed that p44/42 MAP kinase activity was significantly decreased in the prefrontal cortical areas (Brodmann's areas 8, 9 and 10) and the hippocampus of depressed suicide subjects without any change in the cerebellum. This decrease was associated with a decrease in mRNA and protein levels of ERK1 and ERK2. In addition, the expression of MAP kinase phosphatase (MKP)2, a 'dual function' ERK1/2 phosphatase, was increased in the prefrontal cortex and hippocampus. These studies suggest that p44/42 MAP kinases are less activated in the post-mortem brain of depressed suicide subjects and this may be because of reduced expression of ERK1/2 and increased e...Continue Reading

References

Mar 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·J W HaycockE G Krebs
Feb 14, 1992·Biochemical and Biophysical Research Communications·H OwakiT D Geppert
Mar 1, 1992·Molecular and Cellular Biology·R H ChenJ Blenis
Oct 17, 1991·Nature·B J PulvererJ R Woodgett
Jan 8, 1983·British Medical Journal·C Pallis
Nov 24, 1995·Science·Z XiaM E Greenberg
Sep 12, 1995·Proceedings of the National Academy of Sciences of the United States of America·A A ReszkaE H Fischer
Jan 29, 1993·Cell·L L LinR J Davis
Dec 29, 1995·Annals of the New York Academy of Sciences·M A SmithR M Post
Feb 9, 1996·The Journal of Biological Chemistry·J M LaunayL Maroteaux
Apr 30, 1996·Proceedings of the National Academy of Sciences of the United States of America·Y I ShelineM W Vannier
Jan 1, 1996·Annual Review of Neuroscience·R A Segal, M E Greenberg
Jun 6, 1997·Neuroscience Letters·G N PandeyC A Tamminga
Apr 30, 1998·Advances in Cancer Research·T S LewisN G Ahn
Jul 15, 1998·Neuroscience and Biobehavioral Reviews·R Gross-IsseroffA Weizman
Oct 28, 1998·Proceedings of the National Academy of Sciences of the United States of America·D OngürJ L Price
Mar 6, 1999·Current Opinion in Microbiology·F PosasH Saito
Apr 21, 1999·Current Opinion in Cell Biology·T P Garrington, G L Johnson
May 20, 1999·Biological Psychiatry·G RajkowskaC A Stockmeier
Jun 4, 1999·Progress in Biophysics and Molecular Biology·M H Cobb
Jul 28, 1999·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·Y MiyataE Nishida
Sep 3, 1999·Biological Psychiatry·S V KyossevaC N Karson
Oct 6, 1999·Current Opinion in Neurobiology·S S GrewalP J Stork
Dec 3, 1999·Journal of Neurochemistry·P YuanH K Manji

❮ Previous
Next ❯

Citations

Dec 23, 2008·International Journal of Biometeorology·Reija RuuhelaTimo Partonen
Jan 13, 2009·The Cerebellum·Wiljan J A J HendriksJack A M Fransen
Mar 10, 2004·Psychiatry Research·Adolfo SequeiraGustavo Turecki
Oct 19, 2010·Nature Medicine·Vanja DuricRonald S Duman
Nov 27, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Katie LeachArthur Christopoulos
Sep 30, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Boris P Sokolov, Jean L Cadet
Mar 8, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Yogesh DwivediGhanshyam N Pandey
Aug 23, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Natalie C TronsonJelena Radulovic
Sep 14, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Christopher Pittenger, Ronald S Duman
Dec 14, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Yogesh DwivediGhanshyam N Pandey
Aug 25, 2011·Molecular & Cellular Proteomics : MCP·Yaoyang ZhangChristoph W Turck
Dec 25, 2013·PloS One·Chih-Jen HungChun-Jung Chen
Sep 2, 2009·Neuropsychiatric Disease and Treatment·Yogesh Dwivedi
Jun 24, 2008·Neuropsychiatric Disease and Treatment·Francis E Lotrich, Bruce G Pollock
May 7, 2014·European Journal of Pharmacology·Bibiana Mozzaquatro GaiCristina Wayne Nogueira
Aug 28, 2014·Journal of Psychiatric Research·Andiara E FreitasAna Lúcia S Rodrigues
Sep 17, 2014·Nature Reviews. Urology·Qi-Xiang SongMargot S Damaser
Aug 2, 2012·Journal of Cell Communication and Signaling·Yiru Xu, Gary J Fisher
May 16, 2012·Cellular and Molecular Life Sciences : CMLS·Vanja Duric, Ronald S Duman
Jan 31, 2016·Pharmacology & Therapeutics·Linda NguyenRae R Matsumoto
Jan 17, 2016·Journal of Affective Disorders·Xinrong LiKerang Zhang
Mar 27, 2016·Biological Psychiatry·Naoko Abe-HiguchiYoshifumi Watanabe
Apr 10, 2013·Neuroscience and Biobehavioral Reviews·Walter SwardfagerKrista L Lanctôt
Jul 16, 2015·Journal of Women's Health·Ling-yun HuiXuewen Yu
Dec 26, 2012·Medical Hypotheses·Ana Isabelle de Góis QueirozDanielle Silveira Macêdo
Aug 15, 2012·Progress in Neuro-psychopharmacology & Biological Psychiatry·Agata ChandranBeata Karolewicz
Jun 2, 2012·Experimental Cell Research·Yang Guo, Pingfu Feng

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.